SIGA Technologies Inc (SIGA)
8.63
-0.03
(-0.35%)
USD |
NASDAQ |
Apr 25, 10:49
SIGA Technologies Cash from Financing (TTM): -43.42M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -43.42M |
September 30, 2023 | -46.28M |
June 30, 2023 | -46.28M |
March 31, 2023 | -46.93M |
December 31, 2022 | -45.96M |
September 30, 2022 | -48.86M |
June 30, 2022 | -56.16M |
March 31, 2022 | -26.24M |
December 31, 2021 | -26.20M |
September 30, 2021 | -27.16M |
June 30, 2021 | -25.60M |
March 31, 2021 | -34.23M |
December 31, 2020 | -114.60M |
September 30, 2020 | -108.86M |
June 30, 2020 | -103.26M |
March 31, 2020 | -88.04M |
December 31, 2019 | -1.177M |
September 30, 2019 | -2.557M |
June 30, 2019 | -3.857M |
March 31, 2019 | -3.869M |
December 31, 2018 | -3.813M |
September 30, 2018 | -1.792M |
June 30, 2018 | -0.3483M |
March 31, 2018 | -0.3925M |
December 31, 2017 | -0.5856M |
Date | Value |
---|---|
September 30, 2017 | 60.13M |
June 30, 2017 | 58.84M |
March 31, 2017 | 58.89M |
December 31, 2016 | 59.09M |
September 30, 2016 | -1.31M |
June 30, 2016 | -0.0155M |
March 31, 2016 | -0.0033M |
December 31, 2015 | -2.003M |
September 30, 2015 | -2.488M |
June 30, 2015 | -2.988M |
March 31, 2015 | -3.493M |
December 31, 2014 | -2.314M |
September 30, 2014 | -1.054M |
June 30, 2014 | -7.798M |
March 31, 2014 | -0.1434M |
December 31, 2013 | 1.713M |
September 30, 2013 | 5.863M |
June 30, 2013 | 13.11M |
March 31, 2013 | 5.953M |
December 31, 2012 | 4.920M |
September 30, 2012 | -0.2378M |
June 30, 2012 | 0.0808M |
March 31, 2012 | 0.7476M |
December 31, 2011 | 2.593M |
September 30, 2011 | 8.153M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-114.60M
Minimum
Dec 2020
-1.177M
Maximum
Dec 2019
-47.14M
Average
-45.96M
Median
Dec 2022
Cash from Financing (TTM) Benchmarks
Geron Corp | 362.02M |
SELLAS Life Sciences Group Inc | 22.32M |
Heron Therapeutics Inc | 54.11M |
FibroGen Inc | 122.75M |
Clearside Biomedical Inc | 0.414M |